Sooner Health Services, Inc | |
3705 West Main, Bldg 7, Park A, Norman, Oklahoma 73072 | |
(405) 321-7400 | |
Name | Sooner Health Services, Inc |
---|---|
Location | 3705 West Main, Bldg 7, Park A, Norman, Oklahoma |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 377677 |
Ownership Type | Proprietary |
Service Area Zip Codes | 73002, 73003, 73004, 73005, 73008, 73010, 73012, 73013, 73018, 73020, 73026, 73030, 73034, 73036, 73044, 73045, 73051, 73052, 73054, 73059, 73064, 73065, 73066, 73068, 73069, 73071, 73072, 73078, 73080, 73084, 73086, 73089, 73098, 73099, 73105, 73106, 73107, 73108, 73109, 73110, 73111, 73112, 73114, 73115, 73116, 73117, 73118, 73119, 73120, 73121, 73122, 73127, 73128, 73129, 73130, 73132, 73134, 73135, 73139, 73141, 73142, 73149, 73159, 73160, 73162, 73165, 73170, 73179, 73401, 73433, 73438, 73443, 73446, 73448, 73456, 73460, 73463, 73481, 73501, 73502, 73505, 73507, 73565, 74003, 74006, 74008, 74010, 74011, 74012, 74014, 74015, 74016, 74017, 74019, 74020, 74021, 74022, 74023, 74026, 74027, 74028, 74029, 74030, 74033, 74036, 74037, 74038, 74039, 74041, 74044, 74047, 74048, 74051, 74052, 74053, 74055, 74056, 74058, 74063, 74066, 74068, 74070, 74071, 74072, 74073, 74074, 74075, 74079, 74080, 74081, 74083, 74085, 74104, 74105, 74106, 74107, 74108, 74110, 74112, 74114, 74115, 74116, 74117, 74119, 74126, 74127, 74128, 74129, 74131, 74132, 74133, 74134, 74135, 74136, 74137, 74145, 74146, 74148, 74153, 74157, 74332, 74421, 74429, 74437, 74445, 74447, 74501, 74525, 74531, 74576, 74637, 74701, 74759, 74820, 74821, 74826, 74848, 74849, 74851, 74857, 74872, 74884 |
Quality Rating: |
News Archive
IRIN examines how government officials and HIV/AIDS advocates in Zimbabwe are responding to the Global Fund to Fight AIDS, Tuberculosis and Malaria's decision to channel funds through the UNDP rather than the government-operated National AIDS Council (NAC).
Osteosarcoma, a common bone cancer in dogs, affects more than 10,000 dogs in the U.S. each year. While chemotherapy is generally effective at killing some of the cancer cells, the numerous side effects can be painful and often a subset of cancer cells exist that are resistant to chemotherapy.
Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, has been issued an additional U.S. patent covering its AspirinWorks technology and product line.
Vical Incorporated today announced the pricing of an underwritten public offering of 15,000,000 shares of its common stock at a price to the public of $2.25 per share. The gross proceeds to us from this offering are expected to be approximately $33.8 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by us. The offering is expected to close on or about September 29, 2010, subject to customary closing conditions.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for Didanosine Delayed-release Capsules, 125 mg, 200 mg, 250 mg and 400 mg, the generic version of Bristol Myers Squibb's HIV treatment Videx® EC.
› Verified 8 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 98.5 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 99.4 | 98.6 |
How often the home health team checked patients’ risk of falling | 99.9 | 99.6 |
How often the home health team checked patients for depression | 98.3 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 80.8 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 84 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 98.9 | 96.4 |
News Archive
IRIN examines how government officials and HIV/AIDS advocates in Zimbabwe are responding to the Global Fund to Fight AIDS, Tuberculosis and Malaria's decision to channel funds through the UNDP rather than the government-operated National AIDS Council (NAC).
Osteosarcoma, a common bone cancer in dogs, affects more than 10,000 dogs in the U.S. each year. While chemotherapy is generally effective at killing some of the cancer cells, the numerous side effects can be painful and often a subset of cancer cells exist that are resistant to chemotherapy.
Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, has been issued an additional U.S. patent covering its AspirinWorks technology and product line.
Vical Incorporated today announced the pricing of an underwritten public offering of 15,000,000 shares of its common stock at a price to the public of $2.25 per share. The gross proceeds to us from this offering are expected to be approximately $33.8 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by us. The offering is expected to close on or about September 29, 2010, subject to customary closing conditions.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for Didanosine Delayed-release Capsules, 125 mg, 200 mg, 250 mg and 400 mg, the generic version of Bristol Myers Squibb's HIV treatment Videx® EC.
› Verified 8 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 83.9 | 79.6 |
How often patients got better at getting in and out of bed | 78 | 81.1 |
How often patients got better at bathing | 84.5 | 82.3 |
How often patients’ breathing improved | 79.5 | 82.8 |
How often patients’ wounds improved or healed after an operation | 91 | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 74.2 | 75 |
How often home health patients had to be admitted to the hospital | 13.8 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 15 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 97.5 | 94 |
News Archive
IRIN examines how government officials and HIV/AIDS advocates in Zimbabwe are responding to the Global Fund to Fight AIDS, Tuberculosis and Malaria's decision to channel funds through the UNDP rather than the government-operated National AIDS Council (NAC).
Osteosarcoma, a common bone cancer in dogs, affects more than 10,000 dogs in the U.S. each year. While chemotherapy is generally effective at killing some of the cancer cells, the numerous side effects can be painful and often a subset of cancer cells exist that are resistant to chemotherapy.
Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, has been issued an additional U.S. patent covering its AspirinWorks technology and product line.
Vical Incorporated today announced the pricing of an underwritten public offering of 15,000,000 shares of its common stock at a price to the public of $2.25 per share. The gross proceeds to us from this offering are expected to be approximately $33.8 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by us. The offering is expected to close on or about September 29, 2010, subject to customary closing conditions.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for Didanosine Delayed-release Capsules, 125 mg, 200 mg, 250 mg and 400 mg, the generic version of Bristol Myers Squibb's HIV treatment Videx® EC.
› Verified 8 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
IRIN examines how government officials and HIV/AIDS advocates in Zimbabwe are responding to the Global Fund to Fight AIDS, Tuberculosis and Malaria's decision to channel funds through the UNDP rather than the government-operated National AIDS Council (NAC).
Osteosarcoma, a common bone cancer in dogs, affects more than 10,000 dogs in the U.S. each year. While chemotherapy is generally effective at killing some of the cancer cells, the numerous side effects can be painful and often a subset of cancer cells exist that are resistant to chemotherapy.
Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, has been issued an additional U.S. patent covering its AspirinWorks technology and product line.
Vical Incorporated today announced the pricing of an underwritten public offering of 15,000,000 shares of its common stock at a price to the public of $2.25 per share. The gross proceeds to us from this offering are expected to be approximately $33.8 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by us. The offering is expected to close on or about September 29, 2010, subject to customary closing conditions.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for Didanosine Delayed-release Capsules, 125 mg, 200 mg, 250 mg and 400 mg, the generic version of Bristol Myers Squibb's HIV treatment Videx® EC.
› Verified 8 days ago
The patient survey data of Sooner Health Services, Inc is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 87 | 88 |
Percent of patients who reported that their home health team communicated well with them | 85 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 81 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 84 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 77 | 78 |
News Archive
IRIN examines how government officials and HIV/AIDS advocates in Zimbabwe are responding to the Global Fund to Fight AIDS, Tuberculosis and Malaria's decision to channel funds through the UNDP rather than the government-operated National AIDS Council (NAC).
Osteosarcoma, a common bone cancer in dogs, affects more than 10,000 dogs in the U.S. each year. While chemotherapy is generally effective at killing some of the cancer cells, the numerous side effects can be painful and often a subset of cancer cells exist that are resistant to chemotherapy.
Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, has been issued an additional U.S. patent covering its AspirinWorks technology and product line.
Vical Incorporated today announced the pricing of an underwritten public offering of 15,000,000 shares of its common stock at a price to the public of $2.25 per share. The gross proceeds to us from this offering are expected to be approximately $33.8 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by us. The offering is expected to close on or about September 29, 2010, subject to customary closing conditions.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for Didanosine Delayed-release Capsules, 125 mg, 200 mg, 250 mg and 400 mg, the generic version of Bristol Myers Squibb's HIV treatment Videx® EC.
› Verified 8 days ago
Encompass Health Home Health Of Central Oklahoma Location: 209 Nw 48th Ave, Norman, Oklahoma 73072 Ratings: Phone: (405) 360-0041 | |
Completecare Home Health , Llc Location: 15951 Little Axe Drive, Suite 1816, Norman, Oklahoma 73026 Ratings: Phone: (405) 701-7085 | |
Doctors Park Home Health,inc Location: 517 East Robinson Street, Norman, Oklahoma 73071 Ratings: Phone: (405) 360-6060 | |
Lifespring Home Health Location: 2411 Springer Drive, Norman, Oklahoma 73069 Ratings: Phone: (405) 329-4545 | |
Sooner Health Services, Inc Location: 3705 West Main, Bldg 7, Park A, Norman, Oklahoma 73072 Ratings: Phone: (405) 321-7400 | |
Healthback Home Health Of Norman, Inc Location: 226 West Gray, Suite 214, Norman, Oklahoma 73069 Ratings: Phone: (405) 842-1700 |